Most acute patients reach roughly 80 percent of their target improvement by week eight
For example, studies have been looking at the use of GLP-1s for reducing the risk of cardiovascular disease and chronic kidney disease, treatment of nonalcoholic fatty liver disease and Now, two new studies recently presented at the 2026 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS) offer insights on how GLP-1 medications might influence musculoskeletal health, both positively and negatively
[Abstract] Growth curve of male wild type (WT), Slc26a7 +/ , Slc26a7 / , and Slc26a7 -/ mice receiving L-Thyroxine (drinking water containing 0.39 mg/L L-Thyroxine) replacement from day 21 with a low iodine diet
Its main benefits include appetite suppression and improved blood sugar control
The highest dose studied in Phase 2, producing up to 24.2% average weight loss at 48 weeks
Secondly, they may address potential hormonal adaptations that are hypothesised to develop in some post-bariatric patients